Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer.

Shafaee, Maryam Nemati; Makawita, Shalini; Lim, Bora; Ellis, Matthew J; Ludwig, Michelle S

Shafaee, Maryam Nemati; Makawita, Shalini; Lim, Bora; Ellis, Matthew J; Ludwig, Michelle S.

Afiliação

Shafaee MN; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX.
Makawita S; MD Anderson Cancer Center, Houston, TX.
Lim B; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX.
Ellis MJ; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX; Lester and Sue Smith Breast Center, Cancer Center.
Ludwig MS; Cancer Center, Baylor College of Medicine, Houston, TX.

Clin Breast Cancer ; 22(4): e536-e543, 2022 06.

Article em En | MEDLINE | ID: mdl-35184934

Assuntos

Neoplasias da Mama; Neoplasias de Mama Triplo Negativas; Antraciclinas/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Feminino; Humanos; Terapia Neoadjuvante; Neoplasias de Mama Triplo Negativas/tratamento farmacológico; Neoplasias de Mama Triplo Negativas/patologia

Palavras-chave

Concurrent Chemo-radiation; Pathologic complete response; Primary resistant TNBC; Triple negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Limite: Female / Humans Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google